None listed
Conditions
Interventions
Intervention1: Quercetin bar: (i)Oral intervention of quercetin bar 500 mg OD for 14 days
(ii) Oral intervention of quercetin bar 500mg BD (total 1000 mg) for 14 days
Sponsors
Director Defence Institute of Physiology and Allied Sciences
Eligibility
Inclusion criteria
Inclusion criteria: � Subject is a healthy male or female adult, aged 18 to 65 years on the day of enrolment � Subject weighs at least 45 kg � Subject willingness to participate in the study with signed Informed Consent Form
Exclusion criteria
Exclusion criteria: � Subject has any clinically significant illness which is likely to impact the safety of patient or may affect the results of the study � Subject has a known hypersensitivity or allergy to quercetin � Study subject is participating in another drug trial � Study subject is female and is pregnant or may get pregnant during the study period � Study subject unwilling to sign informed consent � Study subject is unlikely to complete the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety and Tolerability of Quercetin Bar in Healthy VolunteersTimepoint: o day, 14th day and 21st day | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse events persisting beyond the last dose of Quercetin barTimepoint: after 14th day of quercetin bar supplementation ie 21st and 28th day | — |
Countries
India
Contacts
Public ContactDr Rashmi Rana
Defence Institute of Physiology and Allied Sciences
Outcome results
None listed